Acta Neuropathologica

, Volume 75, Issue 2, pp 166–172 | Cite as

Necrotizing myopathy with paracrystalline inclusion bodies in hypervitaminosis E

  • A. Bardosi
  • U. Dickmann
Regular Papers

Summary

A necrotizing, nonprogressive myopathy with unusual paracrystalline inclusion bodies is described in a patient who underwent long-term treatment with megadoses of vitamin E. The clinical course and morphological findings suggest a close relationship to the administration of the vitamin. The theoretical pathogenesis of muscle damage and the possible origin of paracrystalline inclusion bodies are discussed.

Key words

Hypervitaminosis E Myopathy Inclusion body 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Balisteri WF, Farrell MK, Bove KE (1986) Lessons from the E-ferol tragedy. Pediatrics 78:503–506Google Scholar
  2. 2.
    Bardosi A, Zobel HJ (1985) A new clamp for muscle and nerve biopsy. Muscle Nerve 8:725Google Scholar
  3. 3.
    Bardosi A, Creutzfeld W, DiMauro S, Felgenhauer K, Friede RL, Goebel HH, Kohlschütter A, Mayer G, Rahlf G, Servidei S, Van Lessen G, Wetterling T (1987) Myoneuro-gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (Berl) 74:248–258Google Scholar
  4. 4.
    Bieri JG, Corash L, Hubbard VS (1983) Medical uses of vitamin E. N Engl J Med 308:1063–1071Google Scholar
  5. 5.
    Boxer LA, Oliver JM, Spielberg SP, Allen JM, Schulman JD (1979) Protection of granulocytes by vitamin E in glutathione synthetase deficiency. N Engl J Med 301:901–905Google Scholar
  6. 6.
    Briggs M (1974) Vitamin E supplements and fatigue. N Engl J Med 290:579–580Google Scholar
  7. 7.
    Burck U, Goebel HH, Kuhlendahl HD, Meier C, Goebel KM (1981) Neuromyopathy and vitamin E deficiency in man. Neuropediatrics 12:267–278Google Scholar
  8. 8.
    Cohen HM (1973) To the Editor: Effects of vitamin E: good and bad. N Engl J Med 289:980Google Scholar
  9. 9.
    Corash L, Spielberg S, Bartsocas C, Boxer L, Steinherz R, Sheetz M, Egan M, Schlessleman J, Schulman JD (1980) Reduced chronic hemolysis during high-dose vitamin E administration in mediterranean-type glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 303:416–420Google Scholar
  10. 10.
    Dickson J, Hopkins DL, Doncon GH (1986) Muscle damage associated with injections of vitamin E in sheep. Aust Vet J 63:231–233Google Scholar
  11. 11.
    Divakaran P, Wiggins RC (1987) Tocopherol in brain metabolism and disease: a review. Metab Brain Dis 2:1–16Google Scholar
  12. 12.
    Ehrenkranz RA, Bonta BW, Ablow RC, Warshaw JB (1978) Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report. N Engl J Med 299:564–569Google Scholar
  13. 13.
    Finer NN, Peters KL, Hayek Z, Merkel CL (1984) Vitamin E and necrotizing enterocolitis. Pediatrics 73:387–393Google Scholar
  14. 14.
    Fragata M, Bellemare F (1980) Model of singlet oxygen scavenging by α-tocopherol in biomembranes. Chem Phys Lipids 27:93–99Google Scholar
  15. 15.
    Graber B, Guggenheim MA, Ringel PC, Neville HE (1980) Neuromuscular disease related to chronic vitamin E deficiency. Ann Neurol 8:217Google Scholar
  16. 16.
    Herbert V (1977) Vitamin E report. Nutr Rev 35:158Google Scholar
  17. 17.
    Hittner HM, Godio LB, Rudolph AJ, Adams JM, Garcia-Prats JA, Friedman Z, Kautz JA, Monaco WA (1981) Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N Engl J Med 305:1365–1371Google Scholar
  18. 18.
    Ishikawa H (1986) Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation. J Cell Biol 38:51–66Google Scholar
  19. 19.
    Johnson L, Bowen FW Jr, Abbasi S, Herrmann N, Weston M, Sacks L, Porat R, Stahl G, Peckham G, Delivoria-Papadopoulos M, Quinn G, Schaffer D (1985) Relationship of prolonged pharmacologic serum levels of vitamin E incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less. Pediatrics 75:619–638Google Scholar
  20. 20.
    Kligman AM (1982) Vitamin E toxicity. Arch Dermatol 118:289Google Scholar
  21. 21.
    Lorch V, Murphy D, Hoersten LR, Harris E, Fitzgerald J, Sinha SN (1985) Unusual syndrome among premature infants associated with a new intravenous vitamin E product. Pediatrics 75:598–602Google Scholar
  22. 22.
    Lucy JA (1972) Functional and structural aspects of biological membranes: a suggested structural role for vitamin E in the control of membrane permeability and stability. Ann NY Acad Sci 203:4–11Google Scholar
  23. 23.
    Murphy BF (1974) Hypervitaminosis E. JAMA 227:1381Google Scholar
  24. 24.
    Natta CL, Machlin LJ, Brin M (1980) A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E. Am J Clin Nutr 33:968–971Google Scholar
  25. 25.
    Neville HE, Ringel SP, Guggenheim MA, Wehling C (1980) Histochemical and ultrastructural abnormalities of muscle in a patient with chronic vitamin E deficiency. Neurology 30:404Google Scholar
  26. 26.
    Neville HE, Ringel SP, Guggenheim MA, Wehling CA, Starcevich JM (1983) Ultrastructural and histochemical abnormalities of skeletal muscle in patients with chronic vitamin E deficiency. Neurology 33:483–488Google Scholar
  27. 27.
    Palmucci L, Anzil AP, Luh S (1983) Crystalline aggregates of protein-glycogen complexes (alias ‘virus-like particles’) in skeletal muscle: report of a case and review of the literature. Neuropathol Appl Neurobiol 9:61–71Google Scholar
  28. 28.
    Phelps DL (1984) E-ferol: what happened and what now? Pediatrics 74:1114–1116Google Scholar
  29. 29.
    Prasad JS (1980) Effect of vitamin E supplementation on leukocyte function. Am J Clin Nutr 33:606–608Google Scholar
  30. 30.
    Rachmilewitz EA, Shifter A, Kahane I (1979) Vitamin E deficiency in β-thalassemia major: changes in hematological and biochemical parameters after a therapeutic trial with α-tocopherol. Am J Clin Nutr 32:1850–1858Google Scholar
  31. 31.
    Roberts HJ (1978) Vitamin E and thrombophlebitis. Lancet I:49Google Scholar
  32. 32.
    Roberts HJ (1979) Thrombophlebitis associated with vitamin E therapy: with a commentary on other medical side effects. Agniology 30:169–176Google Scholar
  33. 33.
    Robert HJ (1981) Perspective on vitamin E as therapy. JAMA 246:129–131Google Scholar
  34. 34.
    Schwarz K (1972) The cellular mechanism of vitamin E action: direct and indirect effects of α-tocopherol on mitochondrial respiration. Ann NY Acad Sci 203:45–52Google Scholar
  35. 35.
    Takenaga K, Honma Y, Hozumi M (1981) Inhibition of differentiation of mouse myeloid leukemia cells by phenolic antioxidants and α-tocopherol. Gann 72:104–112Google Scholar
  36. 36.
    Tappel AL (1972) Vitamin E and free radical peroxidation of lipids. Ann NY Acad Sci 203:12–28Google Scholar
  37. 37.
    Umetsu DT, Couture P, Winter HS, Kagen BM, Bresnan MJ, Lux SE (1980) Degenerative neurological disease in patients with acquired vitamin E deficiency. Pediatr Res 14:512Google Scholar
  38. 38.
    Wahlquist ML, Briggs DR, Jones GP (1982) Vitamins E, C and the B complex. Aust Fam Physician 11:270–278Google Scholar
  39. 39.
    Werlin SL, Harb JM, Swick H, Blank E (1983) Neuromuscular dysfunction and ultrastructural pathology in children with chronic cholestasis and vitamin E deficiency. Ann Neurol 13:291–296Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • A. Bardosi
    • 1
  • U. Dickmann
    • 2
  1. 1.Department of NeuropathologyUniversity of GöttingenGöttingenGermany
  2. 2.Department of NeurologyUniversity of GöttingenGöttingenGermany

Personalised recommendations